NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
822.10
-17.80 (-2.12%)
At close: Feb 13, 2026

NATCO Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
147,560143,064170,522102,795138,013150,529
Market Cap Growth
-29.92%-16.10%65.89%-25.52%-8.31%63.54%
Enterprise Value
118,168120,583160,84193,605133,992144,005
Last Close Price
822.10794.44943.10552.58735.80797.51
PE Ratio
9.487.5912.2814.3781.1834.14
PS Ratio
3.233.234.263.807.097.32
PB Ratio
1.711.882.912.113.243.65
P/TBV Ratio
1.761.953.012.193.343.66
P/FCF Ratio
-11.0419.5514.63-340.56
P/OCF Ratio
-8.4314.0712.11296.8050.38
EV/Sales Ratio
2.592.724.023.466.897.00
EV/EBITDA Ratio
6.575.629.199.6851.5423.74
EV/EBIT Ratio
7.306.1310.2411.56108.5829.19
EV/FCF Ratio
-9.3118.4413.32-325.80
Debt / Equity Ratio
0.030.040.070.040.100.07
Debt / EBITDA Ratio
0.150.130.220.181.640.47
Debt / FCF Ratio
-0.220.440.25-6.42
Net Debt / Equity Ratio
-0.34-0.29-0.17-0.13-0.08-0.13
Net Debt / EBITDA Ratio
-1.65-1.03-0.57-0.64-1.26-0.88
Net Debt / FCF Ratio
--1.71-1.15-0.881.76-12.08
Asset Turnover
-0.570.640.500.390.44
Inventory Turnover
-0.890.940.780.660.66
Quick Ratio
-4.072.732.472.022.48
Current Ratio
-5.594.144.393.504.46
Return on Equity (ROE)
-27.97%25.88%15.66%4.05%11.19%
Return on Assets (ROA)
-15.82%15.63%9.40%1.56%6.57%
Return on Invested Capital (ROIC)
23.50%31.53%28.62%16.41%2.76%11.07%
Return on Capital Employed (ROCE)
-25.60%26.50%16.30%2.80%11.60%
Earnings Yield
10.55%13.18%8.14%6.96%1.23%2.93%
FCF Yield
-9.06%5.12%6.84%-1.35%0.29%
Dividend Yield
0.41%0.76%1.01%1.00%0.61%0.66%
Payout Ratio
-5.72%12.30%14.04%48.35%25.83%
Buyback Yield / Dilution
0.00%0.21%1.67%-0.08%0.04%-0.02%
Total Shareholder Return
0.41%0.97%2.68%0.92%0.66%0.64%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.